SCHEMBL31428577

SCHEMBL31428577

CC(=O)N1C(=Cc2ccccc2OCC(N)=O)C(=O)c2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ HTT P42858 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ CES1 P23141 3/20 0.45
▸ KMT2A Q03164 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ KCNN4 O15554 1/20 0.38
▸ MMP2 P08253 1/20 0.38
▸ MMP3 P08254 1/20 0.38
▸ MMP13 P45452 1/20 0.38
▸ MMP14 P50281 1/20 0.38
▸ PSMD14 O00487 1/20 0.37
▸ HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31428869 0.85 MAPT (0.44) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31428705 0.82 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31428668 0.82 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31428526 0.81 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL30163485 0.81 MAPT (0.53) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31428762 0.81 MAPT (0.47) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31428729 0.81 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31429004 0.80 MAPT (0.53) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31428779 0.79 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL21046448 0.77 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2HTTMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) 2025-03-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND BRAF, RAF1, NRAS ALDH1A1 2352/4885SMN1; SMN2 4832/4885HTT 4442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback